The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)

Radiotherapy and Oncology

Volumn 104, Issue 1, 2012, Pages 96-102

  Daly, Patricia E ^a   Dunne, Mary T ^a   O'Shea, Carmel M ^a   Finn, Marie A ^a   Armstrong, John G ^a  

^a ST LUKE S HOSPITAL   (Ireland)

Author keywords

Erectile function; Neo adjuvant hormone therapy; Prostate cancer; Radiotherapy; Randomised clinical trial

Indexed keywords

FLUTAMIDE; SILDENAFIL; TADALAFIL; TRIPTORELIN; VARDENAFIL;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; EJACULATION; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEXUAL FUNCTION;

EID: 84863185365     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.05.001     Document Type: Article

References (25)

1. S.L. Turner, K. Adams, C.A. Bull, and M.P. Berry Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation Urology 54 1999 124 129 (Pubitemid 29323344)
2. L. Incrocci, A.K. Slob, and P.C. Levendag Sexual (dys)function after radiotherapy for prostate cancer: a review Int J Radiat Oncol Biol Phys 52 2002 681 693 (Pubitemid 34158730)
3. J.W. Robinson, S. Mortiz, and T. Fung Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma Int J Radiat Oncol Biol Phys 54 2002 1063 1068 (Pubitemid 35292617)
4. A.L. Potosky, B.B. Reeve, and L.X. Clegg Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy J Natl Cancer Inst 94 2002 430 437 (Pubitemid 34285092)
5. M.D. Shelley, S. Kumar, and T. Wilt A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma Cancer Treat Rev 35 2009 9 17
6. J.G. Armstrong, C.M. Gillham, and M.T. Dunne A randomized trial (Irish Clinical Oncology Research Group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 81 2011 35 45
7. M. Zelefsky, S. Leibel, and J. Kutcher The feasibility of dose escalation of 3-dimensional conformal radiotherapy in patients with prostatic carcinoma Cancer J Sci Am 1 1995 142 150
8. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
9. Cancer Therapy Evaluation Program, Common terminology criteria for adverse events, Version 3.0, DCTD, NCI, NIH, DHHS; 2006.
10. E.L. Lehmann Nonparametrics. Statistical methods based on ranks 1975 Holden and Day San Francisco
11. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
12. D.R. Cox Regression models and life tables J Res Stat Soc 34 1972 187 220
13. C.T. Chen, and R.K. Valicenti Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiation Oncol Biol Phys 50 2001 591 595 (Pubitemid 32515318)
14. C.J. Beard, and K.J. Propert Complications after treatment with external-beam irradiation in early stage prostate cancer patients: a prospective multiinstitutional outcome study J Clin Oncol 15 1997 223 229 (Pubitemid 27020577)
15. D.S. Lamb, J.W. Denham, and H. Mameghan Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer Radiother Oncol 68 2003 255 267 (Pubitemid 38373426)
16. C.U. Jones, D. Hunt, and D.G. McGowan Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 2011 107 118
17. J. Siglin, G. Kubicek, and B. Leiby Time of decline in sexual function after external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 76 2010 31 35
18. M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468 (Pubitemid 29244857)
19. C.A. Mantz, and J. Nautiyal Potency preservation following conformal radiotherapy for localised prostate cancer: impact of neo-adjuvant androgen blockade, treatment technique and patient-related factors Cancer J Sci Am 5 1999 230 235
20. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74 (Pubitemid 350251041)
21. S. Peeters, W.D. Heemsbergen, and P. Koper Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996 (Pubitemid 46622106)
22. G.J. Van der Wielen, W.L.J. Van Putten, and L. Incrocci Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose escalation trial Int J Radiation Oncol Biol Phys 68 2007 479 484 (Pubitemid 46694167)
23. RTOG 0815 PI: Martinez, AA. A phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer.
24. G.J. Van der Wielen, J.P. Mulhall, and L. Incrocci Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review Radiother Oncol 84 2007 107 113 (Pubitemid 47284535)
25. C. Fiorino, R. Valdagni, T. Rancati, and G. Sanquineti Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167